Pluri Inc. (PLUR)
NASDAQ·Healthcare·Biotechnology
$1.29
+8.40%
Mkt Cap $27.51M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+830.2%
Consensus $12.00 vs current $1.29
NASDAQ·Healthcare·Biotechnology
$1.29
+8.40%
Mkt Cap $27.51M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+830.2%
Consensus $12.00 vs current $1.29